So true. Absent a settlement in those cases (and how does that really when there are many other Generics), it will be years and years for resolutions. That is the part to me that is a weak link in thus BO story. An acquirer will wait so long that patent protection would run out. Well so maybe it has to be some sort of settlement or argreement, who really knows what all parties want.
Market Data 
Markets 
AI
